Surgical Planning Software Market Size, Growth, Trends | Report 2023-2032
The global surgical planning software market was surpassed at USD 102.21 million in 2022 and is expected to hit around USD 192.58 million by 2032, growing at a CAGR of 6.54% from 2023 to 2032.
Key Pointers
Surgical planning software helps surgeons decide the ideal surgical approach by generating digitally accurate data that the surgeon can quickly evaluate before surgery. The technological developments associated with surgical planning software, a rise in cases of orthopedic surgeries, and an increase in the worldwide geriatric population are some of the key factors contributing to the market growth.
The COVID-19 outbreak had a combined impact on the healthcare sector, with certain areas experiencing a negative impact and others experiencing favorable growth. Many nations made the necessary decision to postpone all non-emergency surgical treatment to free up personnel and resources for patients affected by the virus as the healthcare systems globally struggled to cope with the first wave of COVID-19. This led to a reduction in hospital visits, as well as the termination of a significant number of elective surgeries. In 2021, approximately 10 million of the population in the U.K. were waiting for surgical treatments, up from 4 million before the pandemic.
Key Companies & Market Share Insights
The key companies operating in the market are attempting to enhance their product portfolio by upgrading their products and exploring acquisitions and government authorizations to increase their client base and obtain a larger market share. Furthermore, the key players in the market are implementing strategies such as partnerships, mergers and acquisitions, product and service launches, agreements, joint ventures, collaboration, and expansion to strengthen their position in the surgical planning software market.
For instance, In April 2022, GE Healthcare, a medical equipment, and technology provider collaborated with Medtronic, a medical device company. The collaboration was intended to focus on the exceptional demand and need for care at Office-Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs). Under this collaboration, customers can access vast product portfolios, financial solutions, and other exceptional services. In July 2021, DePuy Synthes introduced a robotic-assisted solution named VELYS for knee replacement surgical treatment in Australia. VELYS is planned to be used with the company’s ATTUNE Knee System for complete knee arthroplasty.
In September 2022 Brainlab AG, a digital medical technology provider, acquired Dr. Langer Medical GmbH, a company that specializes in the development of intraoperative neuromonitoring solutions and other related medical devices for surgical procedures. The shared objective of Brainlab & Dr. Langer Medical is to connect entrepreneurship and innovation potential while also creating synergies for the "digital surgery" ecosystem. Some of the major players in the surgical planning software market include:
Surgical Planning Software Market Segmentations:
| By Deployment | By Application | By End-use |
|
Cloud-based On-premise |
Orthopedic Surgery Neurosurgery Dental and Orthodontics Others |
Hospitals Orthopedic Clinics |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Surgical Planning Software Market
5.1. COVID-19 Landscape: Surgical Planning Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Surgical Planning Software Market, By Deployment
8.1. Surgical Planning Software Market, by Deployment, 2023-2032
8.1.1 Cloud-based
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. On-premise
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Surgical Planning Software Market, By Application
9.1. Surgical Planning Software Market, by Application, 2023-2032
9.1.1. Orthopedic Surgery
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Neurosurgery
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Dental and Orthodontics
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Surgical Planning Software Market, By End-use
10.1. Surgical Planning Software Market, by End-use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Orthopedic Clinics
10.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Surgical Planning Software Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.1.2. Market Revenue and Forecast, by Application (2019-2032)
11.1.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.2.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.3.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Deployment (2019-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 12. Company Profiles
12.1. Stryker
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Zimmer Biomet.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Materialise
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Brainlab AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. 3D Systems Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. mediCAD Hectec GmbH
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. DePuy Synthes (Johnson & Johnson Medical Devices Companies).
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. CANON MEDICAL SYSTEMS USA, INC.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. General Electric Company
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers